Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clinical Effectiveness Expected weight loss outcomes with Wegovy Alright, let's get down to the nitty-gritty
An important space for retailers and brands to watch
I feel more energized, supported, and focused on continuing forward
The growth in GLP-1 drug prescriptions for Eli Lilly came during the same holiday week in which Novo Nordisk saw a decline, with its Wegovy and Ozempic GLP-1 drugs falling 4.4% and 1.6% week-over-week, respectively
The GLP-1 receptor agonists segment is estimated to dominate the market due to their efficacy in improving glycemic control while promoting weight loss, making them a preferred option for managing type 2 diabetes
